Mouse embryos with beating hearts have been created entirely in the lab – Freethink

Mouse embryos have now been grown completely from stem cells, without sperm or eggs and outside a mouse womb. The breakthrough, from a lab at the Weizmann Institute of Science, appears to represent an important step in understanding the development of organs, disease, and life as a whole. It may also be just the start. As soon as the science starts to move into a place where its feasible to go from a stem cell population in a Petri dish all the way through to organ development which suggests one day it will be possible to go all the way to creating a living organism its a pretty wild and remarkable time, Paul Tesar, a developmental biologist at Case Western Reserve unaffiliated with the work, told STATs Megan Molteni.

Read more
Zhang and colleagues win an $11.2 million NIH program project grant (PPG) – News – University of Alabama at Birmingham

Zhang wins $11.2 million NIH PPG grant to improve heart attack recovery through growth of new heart muscle cells. Jianyi Jay Zhang, M.D., Ph.D.The National Institutes of Health has awarded a five-year, $11.2 million program project grant, or PPG, to Jianyi Jay Zhang, M.D., Ph.D., and colleagues to study how to restore the dead tissue from a heart attack, through the growth of new heart muscle cells. That is a challenge because mammalian hearts show almost no ability to grow new heart muscle cells, called cardiomyocytes, after birth. After a heart attack from a blocked artery, the dead tissue is not repaired with new cardiomyocytes

Read more
Global Multiple Myeloma Market to Hit Sales of $34.89 Billion By 2028 – GlobeNewswire

Westford, USA, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Multiple myeloma is a cancer of plasma cells in the bone marrow. It is the most common type of leukemia, and the fifth most common cancer around the globe. Prevalence rates of multiple myeloma have more than doubled over the past 30 years and continue to increase, reaching an all-time high of 1.3 million people in 2021. As per SkyQuest analysis of the Multiple Myeloma market, the global prevalence of multiple myeloma is currently pegged at 0.7%, which translates to around 1 case in 132 individuals

Read more
Cell Therapy Technologies Market worth $8.0 billion by 2027 Exclusive Report by MarketsandMarkets – Benzinga

Chicago, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cell Therapy Technologies Marketis projected to grow from USD 4.0 billion in 2022 to USD 8.0 billion by 2027, at a CAGR of 14.6% from 2022 to 2027, according to a new report by MarketsandMarkets. Growth in the market can be attributed to number of cell therapy clinical trials related to cancer. Furthermore, increasing incidence of communicable diseases and the growing risk of pandemics are also expected to fuel the market growth

Read more